Desmopressin Oral — Membership Pricing
Desmopressin Oral is not confirmed for no-additional-cost pricing. Membership pricing may be available; confirm the price with the dispensing pharmacy.
Desmopressin Oral Pricing
| Pricing type | Price |
|---|---|
| TheDrugClub | Membership pricing may be available |
| Typical Retail | $56.00 |
Membership pricing may be available; confirm the price with the dispensing pharmacy.
About Desmopressin Oral
Desmopressin Oral is a prescription medication. Ask your doctor if Desmopressin Oral is right for you.
Other strengths and forms of Desmopressin
How to Check Desmopressin Oral Pricing
- Join TheDrugClub for $19.95/month
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available membership pricing
Desmopressin Oral at Participating Pharmacies
- CVS Pharmacy
- Walgreens
- Walmart Pharmacy
- Rite Aid
- Kroger Pharmacy
- Costco Pharmacy
- Albertsons
- Safeway
- Publix Pharmacy
- H-E-B Pharmacy
Pharmacy participation and fulfillment options vary. Present your membership card and confirm current pricing before filling.
Other medications in Diabetes & Endocrine
What Desmopressin Oral is approved for (FDA label)
Central Diabetes Insipidus: Desmopressin acetate tablets are indicated as antidiuretic replacement therapy in the management of central diabetes insipidus and for the management of the temporary polyuria and polydipsia following head trauma or surgery in the pituitary region. Desmopressin acetate is ineffective for the treatment of nephrogenic diabetes insipidus. Patients were selected for therapy based on the diagnosis by means of the water deprivation test, the hypertonic saline infusion test, and/or response to antidiuretic hormone. Continued response to desmopressin acetate can be monitored by measuring urine volume and osmolality. Primary Nocturnal Enuresis: Desmopressin acetate tablets are indicated for the management of primary nocturnal enuresis.
Source: Read the full FDA label on DailyMed. Label effective date: April 23, 2026.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Adverse reactions for Desmopressin Oral (FDA label)
Infrequently, large doses of the intranasal formulations of Desmopressin Acetate Tablets and Desmopressin Acetate Injection have produced transient headache, nausea, flushing and mild abdominal cramps. These symptoms have disappeared with reduction in dosage. Central Diabetes Insipidus: In long-term clinical studies in which patients with diabetes insipidus were followed for periods up to 44 months of desmopressin acetate tablets therapy, transient increases in AST (SGOT) no higher than 1.5 times the upper limit of normal were occasionally observed. Elevated AST (SGOT) returned to the normal range despite continued use of desmopressin acetate tablets.
Source: FDA prescribing information (DailyMed). Set ID: f140926e-3201-4b8e-8207-14c560ddb55e. SPL document ID: 50265f49-069b-8985-e063-6394a90af552. Label effective date: April 23, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Contraindications for Desmopressin Oral (FDA label)
Desmopressin acetate tablets are contraindicated in individuals with known hypersensitivity to desmopressin acetate or to any of the components of desmopressin acetate tablets. Desmopressin acetate tablets are contraindicated in patients with moderate to severe renal impairment (defined as a creatinine clearance below 50 mL/min). Desmopressin acetate tablets are contraindicated in patients with hyponatremia or a history of hyponatremia.
Source: FDA prescribing information (DailyMed). Set ID: f140926e-3201-4b8e-8207-14c560ddb55e. SPL document ID: 50265f49-069b-8985-e063-6394a90af552. Label effective date: April 23, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Drug interactions for Desmopressin Oral (FDA label)
Although the pressor activity of desmopressin acetate is very low compared to its antidiuretic activity, large doses of desmopressin acetate tablets should be used with other pressor agents only with careful patient monitoring. The concomitant administration of drugs that may increase the risk of water intoxication with hyponatremia, (e.g. tricyclic antidepressants, selective serotonin re-uptake inhibitors, chlorpromazine, opiate analgesics, NSAIDs, lamotrigine and carbamazepine) should be performed with caution.
Source: FDA prescribing information (DailyMed). Set ID: f140926e-3201-4b8e-8207-14c560ddb55e. SPL document ID: 50265f49-069b-8985-e063-6394a90af552. Label effective date: April 23, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.